The influence of ''silent'' cerebrovascular disease on measurement in Alzheimer's disease

被引：0
|
作者：
Lawlor, BA
Swanwick, G
Coen, R
Walsh, JB
Coakley, D
机构：
[1] ST JAMES HOSP,DEPT PSYCHIAT,DUBLIN 8,IRELAND
[2] ST JAMES HOSP,MERCERS INST RES AGEING,DUBLIN 8,IRELAND
来源：
BIOLOGICAL PSYCHIATRY | 1996年 / 39卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [21] Managing treatment expectations in dementia due to cerebrovascular disease or to combined Alzheimer's disease and cerebrovascular disease
    Kurz, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 380 - 380
  • [22] CEREBROVASCULAR AND CARDIOVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE
    de la Torre, Jack C.
    NEUROBIOLOGY OF DEMENTIA, 2009, 84 : 35 - +
  • [23] Long-term treatment with galantamine in patients with Alzheimer's disease and Alzheimer's disease with cerebrovascular disease
    Feldman, H
    Van Baelen, B
    Brashear, HR
    Schwalen, S
    Kavanagh, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S198 - S199
  • [24] Alzheimer's disease, cerebrovascular disease and dementia: lump, split or integrate?
    Biessels, Geert Jan
    BRAIN, 2022, 145 (08) : 2632 - 2634
  • [25] Histological validation of Alzheimer's disease and cerebrovascular disease imaging biomarkers
    Barzee, Brigham
    Hansen, Megan
    Salin, Ashley
    Stone, Megan
    Bridgewater, James
    Kavafyan, Talar
    Steed, Kevin
    Stark, Elena
    Dong, Hongwei
    Toga, Arthur W.
    Vinters, Harry V.
    Wisco, Jonathan J.
    FASEB JOURNAL, 2013, 27
  • [26] Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD
    Erkinjuntti, T
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, : 14 - 23
  • [27] MRI measures of cerebrovascular disease in the Alzheimer's disease neuroirnaging initiative
    Carmichael, Owen
    Drucker, David
    Fletcher, Evan
    Ortega, Mario
    He, Jing
    Yoshita, Mitsuhiro
    DeCarli, Charles
    NEUROLOGY, 2008, 70 (11) : A443 - A443
  • [28] Cerebrovascular disease, Alzheimer's disease biomarkers and longitudinal cognitive decline
    Yates, P. A.
    Villemagne, V. L.
    Ames, D.
    Masters, C. L.
    Martins, R. N.
    Desmond, P.
    Burnham, S.
    Maruff, P.
    Ellis, K. A.
    Rowe, C. C.
    AUSTRALASIAN JOURNAL ON AGEING, 2016, 35 : 18 - 19
  • [29] Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy
    Weller, RO
    Cohen, NR
    Nicoll, JAR
    PANMINERVA MEDICA, 2004, 46 (04) : 239 - 251
  • [30] White matter changes with cerebrovascular disease and Alzheimer's disease pathologies
    Raghavan, Sheelakumari
    Tian, Jianqiao
    Reid, Robert I.
    Przybelski, Scott A.
    Lesnick, Timothy G.
    Lowe, Val J.
    Machulda, Mary M.
    Kantarci, Kejal
    Knopman, David S.
    Petersen, Ronald C.
    Jack, Clifford R.
    Radford, Jonathan Graff
    Vemuri, Prashanthi
    ALZHEIMERS & DEMENTIA, 2023, 19
12345